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Abstract
WWOX, the gene that spans the second most common human chromosomal fragile site, FRA16D, is inactivated in multiple
human cancers and behaves as a suppressor of tumor growth. Since we are interested in understanding WWOX function in
both normal and cancer tissues we generated mice harboring a conditional Wwox allele by flanking Exon 1 of the Wwox
gene with LoxP sites. Wwox knockout (KO) mice were developed by breeding with transgenic mice carrying the Cre-
recombinase gene under the control of the adenovirus EIIA promoter. We found that Wwox KO mice suffered from severe
metabolic defect(s) resulting in growth retardation and all mice died by 3 wk of age. All Wwox KO mice displayed significant
hypocapnia suggesting a state of metabolic acidosis. This finding and the known high expression of Wwox in kidney tubules
suggest a role for Wwox in acid/base balance. Importantly, Wwox KO mice displayed histopathological and hematological
signs of impaired hematopoeisis, leukopenia, and splenic atrophy. Impaired hematopoeisis can also be a contributing factor
to metabolic acidosis and death. Hypoglycemia and hypocalcemia was also observed affecting the KO mice. In addition,
bone metabolic defects were evident in Wwox KO mice. Bones were smaller and thinner having reduced bone volume as a
consequence of a defect in mineralization. No evidence of spontaneous neoplasia was observed in Wwox KO mice. We have
generated a new mouse model to inactivate the Wwox tumor suppressor gene conditionally. This will greatly facilitate the
functional analysis of Wwox in adult mice and will allow investigating neoplastic transformation in specific target tissues.
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Introduction
WW domain-containing oxidoreductase (WWOX) was cloned
and identified as a potential tumor suppressor gene mapping to the
chromosome region 16q23 [1]. The WWOX gene spans .1.1 Mb
and overlaps the common chromosomal fragile site, FRA16D, the
second most common site for chromosomal breakage, instability
and rearrangement of the whole genome [1–3]. Allelic losses and
rearrangements affecting the WWOX locus have been described in
various human cancers [1–5]. Additionally, various studies have
reported significant loss of WWOX expression in multiple human
neoplasias including breast, prostate, ovarian, lung and liver
cancer [6,7].
WWOX is a 46-kD protein, highly conserved through
evolution, that contains two N-terminal WW-domains and a short
chain dehydrogenase/reductase domain (SDR domain) [1]. Our
understanding of the NAD(P)(H)-dependent enzymatic functions
of WWOX is very limited. WWOX’s structure is the archetypal
representative of one of four separate clusters of classical SDRs
conserved through evolution [8,9]. Based on the high expression of
WWOX in hormonally regulated tissues (testis, prostate and ovary)
and its amino acid sequence homology to specific oxidoreductases,
we postulated that WWOX maybe an enzyme involved in sex-
steroid metabolism [1]. The WW-domains are required for
protein-protein interactions through binding the conserved
proline-rich sequence PPXY. Several proteins have been identified
as WWOX protein partners such as SIMPLE, SCOTIN [10] and
EZRIN [11] as well as several transcription factors such as the
tumor suppressor p73[12], ERBB4-CTF [13], AP2c [14], MET-
CTF [15] and the osteoblast differentiation master regulator,
RUNX2 [16], to name a few. One role for WWOX has emerged
as a regulator of transcription by limiting transcription factor
access to the nucleus through cytoplasmic sequestration [6].
T h er o l eo fWWOX as a tumor suppressor is supported by in vitro
studies with human cancer cells and in vivo studies using mouse models.
Several studies reported that ectopic WWOX expression suppressed
the in vivo tumorigenicity of various human tumor types including,
breast [5], lung [17], prostate [18] and ovarian [19] cancer cells when
xenografted in nude mice. Mouse models with targeted disruption of
Wwox had increased spontaneous tumor incidence. Using a conven-
tional mouse knockout approach Aqeilan et al. [20] reported
development of osteosarcomas in some Wwox
2/2 mice by the age of
2.5 weeks and as early as postnatal day 3. All Wwox null mice died by
3–4 wk of age precluding any further studies of adult animals.
However, development of spontaneous lung papillary carcinoma was
observed in adult Wwox
+/2 mice. Aqelian et al [20] also reported that
Wwox
+/2 mice treated with chemical carcinogens displayed an
increased incidence of lymphomas and lung tumors when compared
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Wwox hypomorphic mouse model [21]. Female Wwox hypomorphs
had an increased incidence of spontaneously arising B-cell lymphomas.
In addition, several female developed multiple neoplasias. Together,
t h ei nv i t r oa n di nv i v os t u d i e sh a v eprovided significant evidence for
Wwox as a tumor suppressor.
We are interested in understanding in more detail the normal
and tumor suppressive role Wwox plays in the multiple tissues it is
expressed. As mentioned, Wwox KO mice generated using
conventional techniques die by four weeks of age thus impeding
any studies in adult tissues. Therefore, we report here the
generation of mice with a conditional allele for Wwox ablation
for better understanding the roles of Wwox in different tissues and
in pathological conditions.
Results
Generation of Mice with a Floxed-Wwox Allele
We devised a strategy for conditional ablation of Wwox gene
expression using the Cre-Lox site-specific recombination system.
Our approach, illustrated in Figure 1, utilized positive-negative
selection gene targeting [22] to modify Wwox genomic sequences
by flanking Wwox Exon 1 with two LoxP-recombination sites to
generate a ‘‘floxed’’-Wwox allele. We successfully targeted mouse
ES cells and generated chimeric founders having germline
transmission and subsequently bred a Wwox
flox mouse.
Sinceitwaspossiblethattheinserted pgk-neoplasmid couldimpair
Wwox gene transcription we determined whether the floxed-Wwox
allele had any effect on viability and fertility. Breeding of
heterozygous (Wwox
+/flox) mice from two different founders resulted
in pups having genotypes with the expected Mendelian ratios
demonstrating that the floxed allele had no effect on embryonic
development or viability. Mating of Wwox
flox/flox males with
Wwox
flox/flox females resulted in normal litter size, genotype
frequencies and pups had normal postnatal development. These
results showed that the ‘‘floxed’’-Wwox allele containing the
insertion of the ,2 Kb neomycin resistance gene in the 59
transcriptional control region of the Wwox gene had no detrimental
affect on Wwox functions required for normal mouse growth,
survival or reproduction. Therefore, this mouse model will be a
useful tool for analyzing Wwox function(s) in specific mouse tissues.
Cre-Recombinase Deletion of the Wwox Gene Completely
Ablates Wwox Expression
We showed that our strategy resulted in the specific modification of
the Wwox allele resulting in the insertion of the two LoxP-
recombination sequences flanking Exon 1 however it is possible that
small changes to the inserted sequence could have been introduced
during the procedure. Therefore, to determine whether Cre-recombi-
nase could utilize the inserted LoxP sites to delete Wwox Exon 1, we
generated mice combining the Wwox
flox allele with the Cre-
recombinase gene under the control of the adenovirus EIIA promoter.
TheadenovirusEIIA promoter directstranscriptionofCre-recombinase
at the zygote stage of embryonic development resulting in deletion of
floxed sequences in all cells of the developing embryo including the
germ cells [23]. To determine whether Cre-recombination was
successful we analyzed genomic DNA using PCR with oligonucleotide
primers specific for wild-type or Cre-deleted Wwox sequences (Figure 2).
Using this strategy we were able to test the functionality of the LoxP
sites, determine whether our strategy of deleting Exon 1 would
eliminate Wwox expression and give rise to a phenotype.
We then mated Wwox
flox/flox mice with homozygous EIIA-Cre
transgenic mice that resulted in the first familial generation (F1)o f
Figure 1. Targeting the Mouse Wwox allele. (A) Insertion of the targeting vector into the Wwox allele introduced a new Bgl II (B) restriction site
into Wwox Intron 1. The new Bgl II site leads to a smaller Bgl II restriction fragment when analyzed by Southern blot with the external hybridization
probe. Additionally, a Not I restriction site was engineered at the 39 end of the right arm used to linearize the targeting construct prior to
electroporation. (B) Southern blot genotyping of wild-type (wt/wt) mice, heterozygous mice (wt/flox) and homozygous mice (flox/flox). (C)
Multiplex-PCR based genotyping using allele specific primers. Primers A and B anneal to Wwox specific sequences in the Wwox upstream regulatory
region (primer A) and in Wwox Exon 1 (primer B). Primer C anneals to sequences in the LoxP Cre-recombination in the targeted Wwox allele. Multiplex
PCR using primers A, B and C yield DNA products having sizes specific for the wild-type and targeted alleles.
doi:10.1371/journal.pone.0007775.g001
Wwox Conditional KO Mouse
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allele with Exon 1 deleted (Wwox
+/DCre).Sincethe Wwox
DCre allele was
presentinthegermcellsaF16F1cross shouldresultinpups having all
possible genotypes (Wwox
+/+; Wwox
+/DCre; Wwox
DCre/DCre)w i t h
Mendelian ratios of 1:2:1 (Table 1). Successful matings from all
mating pairs (n=10) were obtained demonstrating that Wwox
+/DCre
mice were fertile having litter sizes ranging between 3 to 11 pups
(average =7.75). Three-day old pups were genotyped by PCR
(Figure 2) and correct Mendelian ratios were obtained after
genotyping 154 animals (p=0.257 using the x
2-test). To demonstrate
that our targeting strategy lead to complete ablation of Wwox
expression we performed immunoblot analysis of total protein
extracts from a variety of tissues (Figure 2). As expected Wwox
protein was undetectable in Wwox
DCre/DCre mice and was reduced by
approximately one-half in heterozygotes confirming that Cre-
mediated deletion of Wwox Exon 1 lead to the complete absence of
Wwox protein.
Ablation of Wwox expression lead to significant growth retardation
that was noticeable at birth (Figure 3A). To further address pup
growth we weighed pups periodically and found that Wwox KO mice
had a severe growth defect averaging only 4.2 g at postnatal day 14
compared to heterozygous and wild-type mice (6.82 and 7.07 g,
respectively). Although some Wwox KO mice can survive up to 3
weeks of age, the mortality rate was very high. As early as 72 h after
birth 43% (15 of 35) of Wwox K O sh a dd i e da n d7 7 %h a dd i e db y1 7
days after birth and no mice survived past weaning. These findings
demonstrated that ablation of Wwox expression by deleting Exon 1
using our Cre-loxP strategy lead to growth retardation and postnatal
death in agreement with the observations of Aqeilan et al [16,20]
using conventional knockout technology.
Ablation of Wwox Expression by EIIA-Cre Mediated
Deletion Resulted in Impaired Hematopoiesis and Splenic
Athrophy
To try to understand the cause of death of Wwox KO mice we
performed necropsies and analyzed blood chemistries of mice at
postnatal day 18. Necropsy results found significantly reduced
relative weights of multiple organs and increased brain weight in
KO mice consistent with wasting (Table 2). Interestingly, spleens
of KO mice were dramatically reduced in size and weight when
compared with those of wild-type and heterozygous. The average
Figure 2. Strategy for Cre-mediated ablation of Wwox expres-
sion. (A) To promote deletion of Wwox
flox alleles we used transgenic
mice carrying the Cre-recombinase gene under control of the adenoviral
EIIA-promoter. EIIA-regulated Cre-recombinase is expressed in pre-
implantation embryos leading to site-specific deletion of LoxP flanked
(floxed) sequences in all tissues including germ cells. (B) PCR-based
strategy to demonstrate Cre-recombinase deletion of the Wwox target
sequences. (C) Wwox protein expression is abolished in Wwox KO mice.
Total protein extracts from the indicated tissues were analyzed by
immunoblottingusingWwoxspecificantibodies.Anti-actinwasusedasa
loading control. WT-wild-type, HET-heterozygous, KO-knockout.
doi:10.1371/journal.pone.0007775.g002
Table 1. Genotypes of pups from Wwox
+/DCre 6Wwox
+/DCre
crosses.
Genotype WT HET KO Total
Actual # of pups 39 85 30 154
Expected # of pups 38.5 77 38.5 154
doi:10.1371/journal.pone.0007775.t001
Figure 3. Wwox KO mice have reduced postnatal growth. (A)
Photograph of WT and KO newborn littermates. (B) F2 pups were
weighed on postnatal days 3, 10, 14 and 17. 100% of Wwox KO mice
died before weaning (21 days). WT, n=18; HET, n=43; KO, n=8. Error
bars represent 6SEM.
doi:10.1371/journal.pone.0007775.g003
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of whole body weight, while spleens from wild-type and
heterozygotes mice weighed on average 4 times as much
representing up to 0.53–0.46% of whole body weight, i.e more
than 2 fold that relative weight of KO mice (p=0.0015) (Table 2).
The histology of the Wwox KO mice spleens was very abnormal
displaying signs of spleen atrophy. As can be observed in Figure 4,
the red pulp displayed dramatically reduced cellularity, although
hematopoietic cells of all series appear to be present. Lymphoid
aggregates of the white pulp of the KO spleens were also reduced
in size compared to the WT spleens.
We also compared the histology of thymus that also displayed
reduced relative weight (p=0.05). We observed that in spite of
preserving relatively normal organ architecture, the cortex of the
thymus of KO mice is significantly thinner than that of wild type
counterparts (Figure 4).
Given these histopathological findings we proceeded to perform
some hematological analyses. White blood counts (WBC) were
estimated manually on blood smears obtained from mice of the
different genotypes. WBC for wild-type mice was estimated at an
average of 9.45610
3 cells per ul (62.25, n=2) while Wwox KO
mice showed signs of leukopenia with lower WBC at an average of
4.2610
3 cells per ul (61.20, n=2). No major differences were
observed in the relative representation of the various white blood
cell subtypes (not shown). However, one of the two KO mice
analyzed displayed 3% of nucleated red blood cells (NRBC)/100
WBCs, a clear sign of severe anemia, while none of the WT mice
showed any NRBCs. In summary, the histopathological and
hematological findings suggest significantly impaired hematopoi-
esis in Wwox KO mice affecting white and red blood cell lineages.
Wwox KO Mice Displayed Signs of Metabolic Acidosis and
Kidney Failure
Most of the parameters measured by blood chemistry were not
significantly different in the Wwox KOs compared with wild-type
and heterozygotes (Table 3). However, glucose levels of Wwox KO
mice were significantly lower than wild-type and heterozygotes
Figure 4. Wwox KO mice have abnormal spleens and thymuses.
Histopathology of spleens (top four panels) and thymuses (bottom four
panels) from 18 day old KO and WT mice. Histological sections were stained
withH&E. Notethesignificantatrophy ofthe spleenand the reduced cortical
thickness in the thymus from the KO mice. Low power images of spleens
(first row) and thymuses (third row) have a total magnification of 21X. High
power images of spleens in (second row) have a total magnification of 84X
and thymuses (bottom row) have a total magnification of 44X.
doi:10.1371/journal.pone.0007775.g004
Table 2. Organ Weights.
Organ WT (n=3) HET (n=3) KO (n=3) p-value***
Spleen (mg) 39.4* 33.3 9.30 0.0015
0.53(60.03)% ** 0.46(60.06)% 0.21(60.03)%
Liver (g) 0.320 0.279 0.144 0.0367
4.0(60.15)% 3.9(60.07)% 3.4(60.29)%
Kidney (g) 0.120 0.110 0.059 NS
1.5(60.03)% 1.5(60.06)% 1.4(60.06)%
Adrenal (mg) 2.27 1.67 2.97 NS
0.03(0.003)% 0.02(60.006)% 0.06(60.029)%
Thymus (mg) 60.0 55.0 25.1 0.0495
0.77(60.05)% 0.77(60.03)% 0.58(60.10)%
Heart 0.063 0.056 0.034 NS
0.79(60.02)% 0.78(60.06)% 0.80(60.03)%
Brain 0.390 0.371 0.356 0.0003
5.0(60.31)% 5.2(60.28)% 8.5(60.65)%
Organ weights are given as average *absolute weight or **absolute weight/
organ weight as a % of body weight (6SEM).
***p-value using student’s t-test comparing WT+HET vs. KO; NS-p.0.05.
doi:10.1371/journal.pone.0007775.t002
Table 3. Blood Chemistry Analysis.
Test WT (n=3) HET (n=3) KO (n=4) p-value**
BUN (mg/dL) 17.6762.60* 18.3361.20 37.2565.73 0.01086
Glucose (mg/dL) 250.665.04 227.0611.7 143.5068.81 0.000131
Total Protein (g/dL) 4.20060.058 4.1060.000 4.1060.252 NS
Albumin (g/dL) 2.7060.000 2.6360.067 2.6060.200 NS
Globulin (g/dL) 1.5060.580 1.4760.067 1.5060.058 NS
Calcium (mg/dL) 11.1360.120 10.8760.120 10.1860.295 0.000385
Phosphorus (mg/dL) 12.6060.306 12.3760.318 12.7360.544 NS
Sodium (Eq/L) 143.0060.577 143.6760.667142.0066.00 NS
Potassium (mEq/L) 8.9760.219 8.9060.252 9.9061.9 NS
Chloride (mEq/L) 108.6760.667 108.6761.20 112.5061.50 0.02769
Total CO2 (mEq/L) 21.6760.333 21.3360.333 14.5063.5 0.006227
Osmolality (mOsmo/kg) 306.2360.517 306.5061.55 304.75614.2 NS
*Values are presented as the average6SEM.
**p-value using student’s t-test comparing WT+HET vs. KO; NS-p.0.05.
doi:10.1371/journal.pone.0007775.t003
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calcium levels were also significantly lower in KO mice
(p=0.0004). More importantly, Wwox KO animals displayed
blood chemistry values compatible with kidney failure since they
showed higher blood urea nitrogen (BUN) (two-fold higher,
p=0.01). In addition, KO mice displayed dramatically reduced
bicarbonate levels (CO2) in blood (p=0.006) indicative of serious
disturbance in the acid/base balance compatible with metabolic
acidosis.
Wwox is Required for Normal Bone Mineralization
Since the KO mice were markedly smaller in size compared to
litter mates and it was previously reported that Wwox KO mice
had defects in bone formation [16] we decided to perform bone
analyses of our Wwox KO mouse. We used micro-computed
tomography (micro-cT) and bone histomorphometry to measure
several parameters of endochondral bone formation. Femurs of
18-day old mice were used for these analyses. Micro-cT analyses
were used to obtain high-resolution scans and constructed 3-D
images to examine morphological features (Figure 5A). We
observed a significant decrease in bone volume and cortical
thickness in Wwox KO mice compared to WT and HETs. Also, it
was evident that cortical porosity and the number of trabeculae
were decreased in Wwox KO mice. We also subjected femurs of
the same mice to detailed histomorphometric analyses. For these
studies sections of femurs were quantified histologically for static
parameters of bone formation such as bone volume, trabecular
number and cell counts. Sections of femurs stained using Von
Kossa that identifies mineralized bone clearly demonstrated a
reduction of bone formation in KO mice (Fig. 5B). The most
significant difference observed in Wwox KO femurs was in bone
volume. Bone volume measurements quantify the volume of
mineralized and non-mineralized portions (osteoid) of the tissue.
The bone volumes of femurs from KO mice were reduced .66%
in comparison to femurs from WT and HET mice (BV/TV %,
13.35% vs. 5.8%, respectively; p,0.01, Fig. 5C). To more clearly
define which parameters of bone formation were impaired in KO
mice, volumes of mineralized and osteoid tissue were determined.
Interestingly, femurs of KO mice were significantly less mineral-
ized compared to WT and HET mice (Md.V/TV %, 13.3% vs.
5.7%, p,0.01, Fig. 5C) and KO mice femurs tended to have more
osteoid than WT and HET femurs (OV/BV %, 0.36% vs. 3.5%,
p=0.07). The number and thickness of trabeculae were also
reduced in femurs of KO mice (Fig. 5C). This was also observed
using micro-cT. This indicates that there was a decrease in bone
formation in Wwox KO mice that is likely due to a lack of
mineralized tissue.
Therefore, to understand the defect of bone formation in Wwox
KO mice we performed histomorphometric measurements of
osteoblast and osteoclast activity. Measurements of osteoclast
activity did not show any differences in femurs from mice of any
genotype. We quantitated osteoblast activity and found that there
were no significant differences in the number of active and non-
active osteoblasts in femurs from all genotypes. Additionally,
osteoblasts of KO mice were healthy, plump, cuboidal cells of
normal morphology. However, there was a significant difference in
the number of active osteoblasts over bone surface (N. Ob/BS) in
femurs of KO mice (p=0.02). This indicates that osteoblasts of
Wwox KO have a defect in mineralization resulting in reduced
bone formation.
A total of nine 18d old Wwox KO mice were subjected to
complete necropsies, X ray analyses and multiple organ
histopathology. We did not observed any lesions compatible with
neoplastic growth by any of the methodologies. Importantly, X ray
analyses did not reveal any bone lesions compatible with
osteosarcoma.
Discussion
The WWOX tumor suppressor gene is inactivated in many types
of human cancers by genomic rearrangements, aberrant mRNA
splicing, homozygous deletions and epigenetic silencing [1–5,24].
Because Wwox KO mice do not survive to adulthood previous
Figure 5. Histomorphometric analysis. (A) MicroCT images of
femurs from postnatal day 18 mice. Note the dramatic difference in
bone structure of the femur from KO mice vs WT and HET mice bones
(B) Von Kossa stained sections of femurs from mice of the indicated
genotypes. Black stained areas represent mineralized bone tissue. Note
the significantly decreased mineralization in the KO mice bone sample
(C) Quantitative histomorphometric analyses of postnatal day 18 day
mice. We did not observe differences between wild-type and
heterozygous mice, therefore, we compared KO data (n=3) with WT
and HET data combined (WT+HET, n=5). Wild-type-WT, heterozygote-
HET, knockout-KO. BV/TV%-bone volume/tissue volume, Md.V/TV%-
mineralized volume/tissue volume, Tb.N-Trabecular number (1/mm),
Tb.Th-Trabecular thickness (micrometers). *p,0.05.
doi:10.1371/journal.pone.0007775.g005
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treatment of Wwox
+/2 mice [20]. Therefore, we have generated
mice carrying a conditional allele of the Wwox tumor suppressor
gene.
In this report we describe the generation and initial character-
ization of a novel mouse model with a conditional Wwox allele. We
utilized adenovirus EIIA-regulated Cre-recombinase transgenic
mice to delete Wwox Exon 1 in all mouse tissues and ultimately
generated Wwox KO mice. We found that Wwox KO mice
suffered from severe metabolic defect(s) resulting in significant
growth retardation, hypoglycemia, impaired hematopoeisis, and
signs of metabolic acidosis that ultimately lead to premature death
of all mice by 3 weeks of age. Bone formation of Wwox KO was
also significantly affected. Bones from KO mice were analyzed and
found to be smaller and thinner having reduced bone volume as a
consequence of a defect in mineralization.
The results of the blood chemistry analysis demonstrated that
Wwox KO mice had severe metabolic defects. Hypoglycemia can
result from multiple causes such as disorders in carbohydrate, fat
or amino acid metabolism as well as endocrine system disorders.
Since Wwox is expressed in a variety of endocrine, neuroendocrine
and non-endocrine tissues it is not possible from these studies to
identify the cause of hypoglycemia. The combination of increased
BUN with reduced bicarbonate levels (hypocapnia) suggests
impaired kidney function and a disturbance in the blood acid-
base balance that would result in acidosis. Protracted acidosis
disturbs many bodily functions and can lead to growth retardation,
bone disease, possibly total kidney failure and ultimately death.
Renal tubular acidosis (RTA) is a pathology that occurs when the
kidneys fail to excrete acids into the urine, which causes the blood
to remain too acidic due to defects of cells in the proximal and
distal convoluted tubules. The convoluted tubules of healthy
kidneys help maintain acid-base balance by excreting acids into
the urine and returning bicarbonate to the blood. Interestingly, we
have previously demonstrated that Wwox is highly expressed in
distal convoluted tubules and to a lesser extent in the proximal
tubules of the kidney in mice (Figure 6) and humans [25]. Given
the pathology observed and the location of Wwox expression in the
kidney we hypothesize that WWOX may play a role in the
regulation of blood pH and maintenance of electrolyte balance.
Thus, we speculate that the lack of Wwox expression in the kidney
tubules in KO mice is likely responsible for the development of
severe metabolic acidosis of renal tubule origin (RTA) that
ultimately leads to death. In addition, as significant contributing
factors to morbidity and death, we also observed severe
histopathological abnormalities affecting hematopoietic organs
such as spleen and thymus in addition to white blood cell counts
compatible with a significant suppression on hematopoiesis
affecting the Wwox KO mice. Specifically, the spleens of Wwox
KO mice displayed signs of atrophy with dramatic reduction in
red pulp cellularity. All studies indicate that Wwox KO mice
suffered from anemia and leukopenia. Anemia can be also
intimately linked to kidney function and to metabolic acidosis.
Additional studies will be required to determine the exact causes of
the impaired hematopoiesis observed as a result of Wwox ablation.
Wwox KO mice have been described to suffer alterations in
bone metabolism [16]. We developed this conditional mouse
model to facilitate the exploration of the cell autonomous
function(s) of Wwox that contribute to the variety of abnormalities
we and others have observed. Therefore, we wanted to determine
whether our mouse model of EIIA-Cre mediated ablation of Wwox
expression recapitulated the observed defects in normal mouse
bone development. We used micro-cT and histomorphometry to
measure several static bone parameters. We observed a decrease of
bone formation in Wwox KO mice associated with a reduction of
mineralization and concomitant increase in osteoid compared to
WT and HET mice. Proper bone formation results from a fine
balance between bone formation and bone resorption. This
balance is mostly maintained by the activity of two bone cell types,
osteoblasts and osteoclasts, that make bone and degrade bone
respectively. We measured osteoblast activity and found no
significant differences in the number of active and non-active
osteoblasts in femurs between genotypes. Measurements of
osteoclast activity did not show any differences in femurs from
mice of any genotype either. This is in sharp contrast to the
observations of Aqeilan et al [16] who observed consistently higher
numbers of osteoclast activity in bone sections of KO mice
however they did not perform quantitative analyses in those
studies. We conclude that Wwox KO mice have reduced bone
formation due to a bone mineralization defect. This is consistent
with previous results that demonstrated a significant defect in
differentiation of Wwox KO calvarial osteoblasts ex vivo compared
to WT osteoblasts [16]. Notably, heterozygous mice did not show
any abnormalities in postnatal growth and survival as well as blood
or bone parameters highlighting that only one Wwox allele is
sufficient for full function.
Importantly, Aqeilan et al. also reported that 4 of 13 (31%) mice
Wwox KO mice developed focal lesions along the femoral
diaphysis compatible with periostal osteosarcoma, lesions observed
in one mice as early as 3d of age [20]. It is worth noting that in
contrast with those previous observations, we did not detect any
lesions compatible with spontaneous osteosarcomas in any of the
Wwox KO mice analyzed macroscopically, histopathologically and
radiographically. Furthermore, none of the long bones that were
subjected to MicroCT analyses revealed any malignant lesions
either. The reason(s) for the discrepancies between studies remain
to be determined.
Very recently a spontaneous mutation in the Wwox gene was
identified in rats that showed severe growth retardation,
experienced epileptic seizures and died without reaching maturity
[26]. The mutation, named lde for lethal dwarfism with epilepsy,
was identified as a 13-bp deletion in Exon 9 of the Wwox gene
resulting in a frame shift mutation causing aberrant amino acid
sequences (371–424aa) at the C-terminal of the Wwox protein.
Remarkably, lde/lde rats displayed phenotypic characteristics
similar to Wwox KO mice including severe dwarfism and early
lethality. The cause of dwarfism is not clear, however, lde/lde rats
had slightly lower bone density and no osteosarcomas developed
during their short life span [27]. Interestingly, lde/lde rats displayed
Figure 6. Wwox is strongly expressed in the kidney tubules.
Kidneys from a WT (left panel) or a KO (right panel) 18 day old mouse
were dissected, paraffin embedded and subjected to immunohisto-
chemical staining using anti-WWOX antibody. The strongest staining
structures represent the distal convoluted tubule section of nephrons.
Photomicrographs were taken using a 40X objective.
doi:10.1371/journal.pone.0007775.g006
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consistent with the blood chemistry of our Wwox KO mice.
In conclusion, we have generated a novel mouse model with a
conditional allele at the Wwox locus. We demonstrated that
homozygous Cre-recombinase mediated deletion of Wwox Exon 1
lead to complete ablation of Wwox expression. Loss of Wwox
expression by this approach resulted in a phenotype similar to the
previously reported Wwox KO generated by conventional
techniques making this Wwox
flox strain an important reagent for
studying Wwox function in normal mouse physiology and tissue
specific tumorigenesis.
Materials and Methods
Animal Husbandry
Mice used in this were kept in a clean, modified-barrier animal
facility, fed regular commercial mouse diet (Harlan Lab.,
Indianapolis, IN) under controlled light (12L:12D) and tempera-
ture (68–74uF). All animal research was conducted in facilities
accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALAC) at the Univer-
sity of Texas, M.D. Anderson Cancer Center, Science Park
Research Division, following international guidelines and all
research was approved by the corresponding Institutional bioethics
committee (IACUC).
Gene Targeting and Generation of a Wwox-Floxed Allele
The Wwox targeting construct was generated using ,6K bo f
Wwox gene obtained from BAC clone 9N99 containing a 59
portion of the Wwox gene from 129/svJ mouse genomic DNA.
Primers used for generating the targeting construct were: Right
arm forward, 59-CAAAACCCGGAAACTGGATTACAGC-39;
Right arm reverse, 59-CCTAGACTGTGCTGCTCCAA-39;
Left arm forward, 59-GAGGAGGAGGAGGAGGGAAGTA-
GAGG-39; Left arm reverse, 59-CAGCTACTGGCGG-
GAAAGGG-39. First, a ,4 Kb genomic sequence containing
Wwox Exon1 and a portion of Intron 1 was PCR amplified and
cloned into plasmid pK-11 [28]. pK-11 contains the neomycin
transferase gene under control of the phosphoglycerol kinase promoter
(pgk-neo) used as the positive-selection element and a single LoxP
Cre-recombinase recognition site. Another LoxP Cre-recombinase
recognition site was inserted into Wwox Intron 1 in the same
orientation as the pK-11 LoxP site in order to ‘‘flox’’ Wwox Exon 1
(Wwox
flox) resulting in the plasmid pK-11-Wwox-flox. The left arm
of the targeting construct was generated by cloning ,2 Kb of the
Wwox 59 upstream sequence into the plasmid pBJ101-DT [22].
Plasmid pBJ101-DT contains the diphteria toxin A-chain gene (DT-A)
used as the negative-selection element. The final targeting
construct was generated by transferring the DT-A gene and Wwox
left arm sequences to pK-11-Wwox-flox plasmid (Figure 1A).
The Wwox target construct was then used by the UT MD
Anderson Genetically Engineered Mouse Facility (GEMF) for
generation of targeted ES cells and mouse chimeras. ES cell clones
were electroporated with the Wwox targeting vector that had been
linearized by digestion with Not I restriction endonuclease.
Transfected ES cells were selected for G418-resistance and
individual clones screened by Southern hybridization. Genomic
DNA was digested with Bgl II and hybridized to a probe
corresponding to a region of Wwox Intron 1 outside of the
targeting construct sequences (Figure 1A). Correctly targeted ES
cells were identified by hybridization to two Bgl II restriction
fragments of ,9 Kb and ,4 Kb representing the Wwox
+ and
Wwox
flox alleles, respectively (Figure 1A,B). The hybridization
probe was generated by PCR amplification with the following
primers: HYB probe reverse, 59-TCCTTCTGCCAAATCC-
CGTTATGC-39, HYB probe forward, 59-CAAAACTCAAAG-
TAGAAAGAACAAGG-39 using 129/svJ mouse genomic DNA
as a template. Two correctly targeted ES cell lines were identified
from 240 ES cell clones screened.
Injections of targeted ES cells into C57BL/6 blastocysts were
performed to generate male chimeras that were mated to C57BL/
6 females to test for germline transmission of the Wwox
flox allele.
Tail DNA samples from agouti offspring were genotyped by
Southern hybridization. Wwox
+/flox offspring were then used as the
F1 generation for subsequent use. After establishing Mendelian
transmission of the Wwox
flox allele genotyping was performed using
a multiplex PCR method (Figure 1C,D). The following primers
were used for PCR genotyping: Primer A: 59-ATGGGAC-
GAAACTGGAGCTCAGAA-39; Primer B: 59-TCAGCAACT-
CACTCTGGCTTCAAC-39; Primer C: 59-GCATACATTA-
TACGAAGTTATTCGAG-39.
Generation of Wwox Knockout Mice Using EIIA-Cre
Mediated Deletion
Female Wwox
flox/flox mice were bred with male mice homozy-
gous for the Cre-recombinase gene under the control of the
adenovirus EIIA-promoter to generate the Wwox
+/DCre F1 gener-
ation. EIIA-Cre transgenic mice [23] were obtained from The
Jackson Laboratory (Bar Harbor, ME; stock number: 003724).
Genotypes were determined by PCR using the oligonucleotide
primers: Primer X: 59-GCCCCCTTTCCCGCCAGTAGCTG-
39; Primer Y: 59-GACCCAGATCCCCTAATAACG-39; Primer
Z: 59-GCCCTCAAGAAGAGGCTGCAATTT-39.
Western Blot Analysis
Mouse tissues were dissected and flash frozen in liquid nitrogen
then crushed into a fine powder with a mortar and pestle. Total
protein lysates were made by suspension of crushed tissue with lysis
buffer (1% Igepal CA-630, 50 mM Tris-Cl, pH 7.5, 150 mM
NaCl, 5 mM EDTA, 10% glycerol) containing protease inhibitors
and incubation at 4uC for 30 min. with constant agitation.
Insoluble material was then removed by centrifugation at 10,000 x
g for 10 min. at 4uC. Protein concentration was determined using
the BCA method (Pierce, Rockford, IL). Western blot analysis was
performed as previously described [21] using 30 mg of total
protein. WWOX protein was detected using a rabbit polyclonal
antibody raised against the WWOX WW-domains [24]. The
amount of b-actin in each sample was used as an internal control.
b-actin was detected using a mouse monoclonal antibody (Sigma
Aldrich, St. Louis, MO).
Mouse Necropsy and Histological Analyses
Mice were euthanized by CO2 asphyxiation, organs harvested
and immediately weighed using a Mettler AE50 analytical
balance.Organs were then fixed in formalin for 24 hours, then
70% ethanol and embedded in paraffin. Tissue sections were
stained in H&E or processed for immunostaining. Blood was
collected immediately following euthanasia by intracardiac
puncture on the left ventricule and allowed to clot at room
temperature for 30 minutes. Serum was collected following
centrifugation for 10 minutes at 14,000 rpm at 4uC. Blood
chemistries were measured using serum from each individual
mouse using the Olympus AU400 automated chemistry analyzer.
Manual differential and WBC were obtained from feathered
blood smears using fresh whole blood from each individual
animal.
Wwox Conditional KO Mouse
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Limbs were dissected and soft tissue was carefully removed then
fixed in formalin for 48 hours followed by 70% ethanol.
Microcomputed tomography (micro-cT) was performed at the
Baylor College of Medicine MicroCT Core facility. Bone
histomorphometric analyses were performed at the UT MD
Anderson Bone Histomorphometry Core Laboratory (Director,
Dr Nora Navone) following the guidelines established by the
American Society for Bone and Mineral Research (ASMBR)
histomophometry nomenclature committee.
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